Overview

Osteoarthritis Therapeutics Market is poised to value USD 13262 million by 2028 end at a CAGR of 8.8% during the forecast period 2022 to 2028.

Osteoarthritis is a chronic health condition that causes chronic pain and disability with reduced mobility. Degenerative arthritis in joints occurs when cartilage in one or more joints breaks down and eventually loses its integrity. The cartilage of joints between bones, such as those in the knees, ankles, and elbows, provides support and flexibility. Providing lubrication and reducing friction in the joint are its main benefits. As part of osteoarthritis treatment, the goal is to enhance both functional abilities and alleviate pain. In addition to the increase in osteoarthritis prevalence, advancements in research and development for drug development, increasing funding from private and government organizations to develop healthcare centers and research centers, and an increase in cell-based research activities are major factors contributing to the growth of the osteoarthritis therapeutics market. An article was published in Stem Cell International describing a new approach for treating osteoarthritis with mesenchyme stem cells. A rise in the number of drugs approved for prescription will drive the growth of the infectious disease diagnostic market. As well, a growing geriatric population fuels the growth in osteoarthritis therapeutics, owing to the fact that older people are more likely to develop the disease. In the treatment of OA, NSAIDs are the most effective oral medications. The most common of these are ibuprofen (Motrin, Advil), naproxen (Aleve) and diclofenac (Voltaren, among others). In all cases, these medications block enzymes that cause pain and swelling. Unfortunately, some of these enzymes also keep blood clots from forming and protect stomach linings from damage.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Osteoarthritis Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Osteoarthritis Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Osteoarthritis Therapeutics Market:

  • Sanofi
  • Horizon Therapeutics PLC
  • Johnson & Johnson
  • Glaxosmithkline PLC
  • Bayer AG
  • Abbott
  • Pfizer, Inc.
  • Eli Lilly
  • Anika Therapeutics, Inc.
  • Novartis
  • Ferring Pharmaceuticals
  • Bioventus
  • Zimmer Biomet Holdings, Inc.
  • Fidia Farmaceutici S.P.A.
  • Flexion Therapeutics, Inc.

 (Note: The list of the major players will be updated with the latest market scenario and trends)

Osteoarthritis Therapeutics Market Segmentation:

By Anatomy

  • Knee
  • Hip
  • Hand
  • Small Joints (Foot & Ankle and Wrist)

By Drug Type

• Viscosupplementation Agents
• Nonsteroidal Anti-inflammatory Drugs
  o Naproxen
  o Aspirin
  o Diclofenac
  o Ibuprofen
  o Other NSAIDs
• Analgesics
  o Duloxetine
  o Acetaminophen
• Corticosteroids

By Route of Administration

  • Parenteral
  • Topical
  • Oral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Purchasing Pattern

  • Prescription Drug
  • Over-the-counter Drug

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the Osteoarthritis Therapeutics Market By Anatomy, By Drug Type, By Route of Administration, By Distribution Channel, By Purchasing Pattern and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics